This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
Small win for improved access to naloxone
Monday 1 August 2022, 04:30 AM
Drug Foundation policy director Kali Mercier wishes the MCC had made naloxone a generalsale medicine [Image – Hagen Hopkins Photography]
The NZ Drug Foundation is pleased the Medicines Classification Committee has removed some of the red tape blocking access to the lifesaving, overdosereversal medication naloxone, although it wishes the committee’s recommendations had gone further.
We had hoped the MCC would have gone further and made all types of naloxone available over the counter
At its meeting on 26 April, which has its